The results showed that in the high ZNF529-AS1 expression group, risk scores were positively correlated with most immune pathways, including DNA replication, cell cycle, Fanconi anaemia pathway, homologous recombination, mismatch repair, nucleotide excision repair, oocyte meiosis, viral carcinogenesis, base excision repair, p53 signalling pathway, spliceosome, progesterone-mediated oocyte maturation, microRNAs in cancer, pyrimidine and RNA degradation (Fig. 8A, B). This evidence concerns the gene ZNF529 and cancer.